MA moves to revoke license of pharmacy linked to meningitis outbreak
Inspectors have finished the first stage of an investigation at the compounding pharmacy that produced the steroids linked to the fungal meningitis outbreak, New England Compounding Center in Framingham. The inspection paints a picture of a pharmacy poised for problems. One claim is that batches of the steroid linked to deaths across the country were shipped out before NECC pharmacists had even confirmed they were safe.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- 3 Traits Personality Assessments Can't Reveal
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Carondelet to Pay $35M to Settle Fraud Allegations
- CHS Hacked, 4.5M Patient Records Compromised